Evoke Pharma Stock Scheduled to Reverse Split on Thursday, August 1st (NASDAQ:EVOK)

Shares of Evoke Pharma, Inc. (NASDAQ:EVOK) are set to reverse split on the morning of Thursday, August 1st. The 1-12 reverse split was announced on Thursday, August 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, August 1st.

Evoke Pharma Price Performance

Shares of EVOK traded down $0.08 during midday trading on Tuesday, reaching $0.42. 112,058 shares of the stock were exchanged, compared to its average volume of 42,557. The business’s 50-day moving average price is $0.52 and its 200 day moving average price is $0.57. Evoke Pharma has a twelve month low of $0.36 and a twelve month high of $1.67. The company has a market capitalization of $3.59 million, a price-to-earnings ratio of -0.23 and a beta of 0.38.

Evoke Pharma (NASDAQ:EVOK) last posted its earnings results on Tuesday, May 14th. The specialty pharmaceutical company reported ($0.17) EPS for the quarter. Evoke Pharma had a negative return on equity of 4,908.09% and a negative net margin of 116.75%. The firm had revenue of $1.74 million for the quarter.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on Evoke Pharma in a research report on Tuesday, July 23rd. They set a “sell” rating on the stock.

About Evoke Pharma

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.